• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Xylo Technologies Ltd.

    8/8/25 9:00:02 AM ET
    $XYLO
    Medical/Dental Instruments
    Health Care
    Get the next $XYLO alert in real time by email
    6-K 1 ea0252330-6k_xylotech.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of August 2025

     

    Commission File Number 001-37381

     

    XYLO TECHNOLOGIES LTD.
    (Translation of registrant’s name into English)

     

    10 HaNechoshet Street, Tel-Aviv, 6971072, Israel

    (Address of principal executive offices)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

     

    Form 20-F ☒   Form 40-F ☐

     

     

     

     

     

     

    EXPLANATORY NOTE

     

    On August 4, 2025, Xylo Technologies Ltd. (the “Company”), among other investors, entered into a definitive securities purchase agreement (the “Securities Purchase Agreement”) with ParaZero Technologies Ltd. (“ParaZero”) for the purchase of (i) 581,818 of ParaZero’s ordinary shares, par value NIS 0.02 per share (the “Ordinary Shares”), and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 100,000 Ordinary Shares, in a registered direct offering at a purchase price of $1.10 per Ordinary Share and $1.09999 per Pre-Funded Warrant, for the aggregate amount of $750,000.

     

    The Pre-Funded Warrants are exercisable at an exercise price of $0.00001 per Ordinary Share, subject to adjustment as set forth therein, and do not expire until exercised in full. The Pre-Funded Warrants can be exercised on a cashless basis.

     

    A holder of the Pre-Funded Warrants does not have the right to exercise any portion of its Pre-Funded Warrants if the holder (together with such holder’s affiliates, and any persons acting as a group together with such holder or any of such holder’s affiliates or any other persons whose beneficial ownership of Ordinary Shares would be aggregated with the holder’s or any of the holder’s affiliates), would beneficially own Ordinary Shares in excess of 4.99% of the number of the Ordinary Shares outstanding immediately after giving effect to such exercise.

     

    The Securities Purchase Agreement also contains representations, warranties, indemnification and other provisions customary for transactions of this nature.

     

    Forward-Looking Statements

     

    This Report on Form 6-K contains statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. These forward looking statements are based upon the Company’s present intent, beliefs or expectations, but forward looking statements are not guaranteed to occur and may not occur for various reasons, including some reasons which are beyond the Company’s control. For example, Company cannot guarantee ParaZero’s future performance, or that its investment in ParaZero will generate positive results. Furthermore, actual results may differ materially from those projected or implied due to various risks and uncertainties. For this reason, among others, you should not place undue reliance upon the Company’s forward looking statements. Except as required by law, the Company undertakes no obligation to revise or update any forward looking statements in order to reflect any event or circumstance that may arise after the date of this Report on Form 6-K.

     

    1

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      Xylo Technologies Ltd.
         
    Date: August 8, 2025 By: /s/ Tali Dinar
        Tali Dinar
        Chief Financial Officer

     

    2

     

    Get the next $XYLO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $XYLO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $XYLO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Xylo Technologies: Viewbix Shares to Begin Trading on Nasdaq

    TEL AVIV, Israel, June 05, 2025 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (NASDAQ:XYLO) ("Xylo" or the "Company"), a technology-based company engaged in advanced innovative technologies, announced today that Viewbix Inc. (NASDAQ:VBIX), a global developer of ad-tech innovative technologies, has received approval for its shares of common stock to be listed on the Nasdaq Capital Market. Viewbix, in which Xylo holds an indirect stake through its 45.74% ownership in Gix Internet Ltd. ("Gix Internet"), which in turn owns 2,818,585 common shares representing 42.58% of Viewbix, expects its shares to commence trading on Nasdaq under the symbol "VBIX" on or about June 5, 2025, subject to continued

    6/5/25 9:21:00 AM ET
    $MDGS
    $XYLO
    Medical/Dental Instruments
    Health Care

    Xylo Technologies: Charging Robotics Successfully Installs Wireless EV Charging System in Automatic Parking Facility

    TEL AVIV, Israel, April 30, 2025 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (NASDAQ:XYLO) ("Xylo" or the "Company"), a technology-based company engaged in advanced innovative technologies, announced today that Charging Robotics, Inc. (OTC:CHEV) ("Charging Robotics"), a Delaware corporation (62.22% owned by Xylo), has successfully installed a system for wireless charging of electric vehicles with a leading supplier of robotic parking facilities.  Following the installation, the system successfully demonstrated the ability to wirelessly transfer power.  The system is intended to be used for charging electric vehicles ("EVs") while reporting charge data to the cloud and managing the charging

    4/30/25 9:12:00 AM ET
    $MDGS
    $XYLO
    Medical/Dental Instruments
    Health Care

    Xylo Technologies: Revoltz Secures First Institutional Client for PORTO EV Logistics Deployment

    TEL AVIV, Israel, April 29, 2025 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (NASDAQ:XYLO) ("Xylo" or the "Company"), a technology-based company engaged in advanced innovative technologies, announced today that Revoltz Ltd. ("Revoltz"), which is 19.9% held by Charging Robotics, Inc. (OTC:CHEV) ("Charging Robotics"), a Delaware corporation quoted on the OTC Market (62.22% owned by Xylo), has secured its first institutional client for the PORTO EV, Revoltz's flagship electric micro-vehicle designed for last-mile logistics. The new order marks a significant step in Revoltz's commercial expansion strategy, transitioning from individual sales into larger fleet deployments. The institutional cus

    4/29/25 6:34:08 AM ET
    $MDGS
    $XYLO
    Medical/Dental Instruments
    Health Care

    $XYLO
    SEC Filings

    View All

    SEC Form EFFECT filed by Xylo Technologies Ltd.

    EFFECT - XYLO TECHNOLOGIES LTD (0001618500) (Filer)

    8/26/25 12:15:01 AM ET
    $XYLO
    Medical/Dental Instruments
    Health Care

    SEC Form 15-12G filed by Xylo Technologies Ltd.

    15-12G - XYLO TECHNOLOGIES LTD (0001618500) (Filer)

    8/22/25 4:00:04 PM ET
    $XYLO
    Medical/Dental Instruments
    Health Care

    SEC Form 25-NSE filed by Xylo Technologies Ltd.

    25-NSE - XYLO TECHNOLOGIES LTD (0001618500) (Subject)

    8/22/25 9:06:32 AM ET
    $XYLO
    Medical/Dental Instruments
    Health Care